2023-03-22 17:35:56 ET
- ADMA Biologics ( NASDAQ: ADMA ) is scheduled to announce Q4 earnings results on Thursday, March 23rd, after market close.
- The consensus EPS Estimate is -$0.07 (+22.2% Y/Y) and the consensus Revenue Estimate is $48.07M (+82.2% Y/Y).
- Over the last 1 year, ADMA has beaten EPS estimates 75% of the time and has beaten revenue estimates 100% of the time.
- Over the last 3 months, EPS estimates have seen 0 upward revisions and 1 downward. Revenue estimates have seen 3 upward revisions and 0 downward.
For further details see:
ADMA Biologics Q4 2022 Earnings Preview